FEDRATINIB
Fedratinib 100 mg capsule, 120
FEDRATINIB (15278D)
15278D
Manner of administration:Oral
Restriction
Indication: High risk and intermediate-2 risk myelofibrosis
Treatment phase: Initial treatment
Restriction
Indication: Intermediate-1 risk myelofibrosis
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 120 | # of repeats: 5 | DPMQ: $5,800.71 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Inrebic | |||||